Arbormed Co., Ltd.
- Biotech or pharma, therapeutic R&D
Arbormed is a IND stage rare disease company focused on development of novel therapies for genetic disorders. We plan to start a clinical study for ARBM-101 for the treatment of Wilson's Disease in 2H 2025. We has also completed in vivo efficacy study for ARBM-301 for the treatment of Congenital Hearing Loss and look for R&D collaboration partner.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}